| |
 |
|
|
Science Forum Index » Medicine - Nursing Forum » Pediatric bipolar disorder: An object of study in the...
Page 1 of 1
|
| Author |
Message |
| JOHN... |
 Posted: Sat Jul 19, 2008 3:20 pm |
|
|
|
Guest
|
| http://psychrights.org/Articles/DHealy2007PediatricBipolarDisorderJRS419.pdfPediatric bipolar disorder: An object of study in the creation of anillness, by David Healy and Joanna Le Noury, International Journal of Risk &Safety in Medicine, 19 (2007) 209-221.As outlined above, a number of forces appear to have swept aside traditionalacademic skepticism with the result that an increasing number of childrenand infants are being put on cocktails of potent drugs without any evidenceof benefit..........If the process outlined here was one that could reasonably beexpected to lead to benefits it could regarded as therapeutic. But giventhat there is no evidence for benefit and abundant prima facie evidence thatgiving the drugs in question to vulnerable subjects in such quantitiescannot but produce consequent difficulties for many of these minors, one hasto wonder whether we are not witnessing instead a variation on Munchausen'ssyndrome, where some significant other wants the individual to be ill andthese significant others derive some gain from these proxy illnesses. |
|
|
| Back to top |
|
| Peter Parry... |
| Posted: Sat Jul 19, 2008 3:42 pm |
|
|
|
Guest
|
On Sat, 19 Jul 2008 21:20:12 +0100, "JOHN" <john at (no spam) nospam.com> wrote:
From that paper "In the past 10 years D. Healy has had consultancies
with, been a principal investigator or clinical trialist for, been a
chairman or speaker at international symposia for or been in receipt
of support to attend meetings from Astra-Zeneca, Boots/Knoll
Pharmaceuticals, Eli Lilly, Janssen-Cilag, Lorex-Synthelabo, Lundbeck,
Organon, Pharmacia & Upjohn, Pierre-Fabre, Pfizer, Rhone-Poulenc
Rorer, Roche, Sanofi, SmithKline Beecham, Solvay. In the past two
years, he has had lecture fees and support to attend meetings from
Astra-Zeneca and Lundbeck.
How do you normally describe people with such credentials? |
|
|
| Back to top |
|
| D. C. Sessions... |
| Posted: Sat Jul 19, 2008 4:02 pm |
|
|
|
Guest
|
In message <6ak484pil98sifk6bh1tcvhrld6po11kf5 at (no spam) 4ax.com>, Peter Parry wrote:
Quote: How do you normally describe people with such credentials?
The only thing that John needs to know about someone's
credentials is whether or not they agree with him.
--
| "Ridicule is the only weapon which can be used against |
| unintelligible propositions. Ideas must be distinct |
| before reason can act on them" -- Thomas Jefferson |
+-------- D. C. Sessions <dcs at (no spam) lumbercartel.com> ---------+ |
|
|
| Back to top |
|
| Jan Drew... |
| Posted: Sun Jul 20, 2008 10:57 am |
|
|
|
Guest
|
"Peter Parry" <peter at (no spam) wpp.ltd.uk> wrote in message
news:6ak484pil98sifk6bh1tcvhrld6po11kf5 at (no spam) 4ax.com...
Quote: On Sat, 19 Jul 2008 21:20:12 +0100, "JOHN" <john at (no spam) nospam.com> wrote:
http://psychrights.org/Articles/DHealy2007PediatricBipolarDisorderJRS419.pdfPediatric
bipolar disorder: An object of study in the creation of an illness,
by David Healy and Joanna Le Noury,
From that paper "In the past 10 years D. Healy has had consultancies
with, been a principal investigator or clinical trialist for, been a
chairman or speaker at international symposia for or been in receipt
of support to attend meetings from Astra-Zeneca, Boots/Knoll
Pharmaceuticals, Eli Lilly, Janssen-Cilag, Lorex-Synthelabo, Lundbeck,
Organon, Pharmacia & Upjohn, Pierre-Fabre, Pfizer, Rhone-Poulenc
Rorer, Roche, Sanofi, SmithKline Beecham, Solvay. In the past two
years, he has had lecture fees and support to attend meetings from
Astra-Zeneca and Lundbeck.
How do you normally describe people with such credentials?
He's an expert on anti-depressant drugs such as Prozac and the center
offered him a prestigious job. But then suddenly it changed its mind. The
decision the critics say was influenced by the center's relationship with
powerful drug companies. Darrow MacIntyre has this feature documentary.
DAVID HEALY: Let's say in the case of Prozac that it causes the problem, it
will cause people to commit suicide at a rate of one in 1,000 people who
actually go on the drug. To most people here a figure like that, that sounds
like a fairly low figure. It sounds like a reasonable trade-off almost. But
if 50 million people go on the drug, then that becomes 50,000 suicides which
is maybe higher than there has been, but it becomes an awfully big figure.
It's what the FDA call the public health multiplier which is a small hazard
distributed among millions of people becomes a big problem.
http://psychrights.org/Research/Legal/SStefanPsychMedstortlitigationFactSheet.htm
Dr. Healy's credentials were impeccable, and therefore he was permitted to
testify. ... |
|
|
| Back to top |
|
| Peter Parry... |
| Posted: Sun Jul 20, 2008 1:53 pm |
|
|
|
Guest
|
On Sun, 20 Jul 2008 11:57:14 -0400, "Jan Drew"
<jdrew1374 at (no spam) sbcglobal.net> wrote:
Quote: Dr. Healy's credentials were impeccable, and therefore he was permitted to
testify. ...
I don't doubt for one minute that they are. However if anyone with
similar credentials were to be quoted on, say, the subject of vaccine
safety John would be jumping up and down and writing "pharma shill"
or similar. I'm just puzzled how someone who (quite properly) works
for many drug companies can be a "noted expert" (if they support
John's viewpoint) but a "pharma shill" (if they don't). This doesn't
seem to be a very consistent approach to debate. |
|
|
| Back to top |
|
| D. C. Sessions... |
| Posted: Sun Jul 20, 2008 2:53 pm |
|
|
|
Guest
|
In message <iu1784hg76smt1g5ddvag655tbme32jcqc at (no spam) 4ax.com>, Peter Parry wrote:
Quote: I don't doubt for one minute that they are. However if anyone with
similar credentials were to be quoted on, say, the subject of vaccine
safety John would be jumping up and down and writing "pharma shill"
or similar. I'm just puzzled how someone who (quite properly) works
for many drug companies can be a "noted expert" (if they support
John's viewpoint) but a "pharma shill" (if they don't). This doesn't
seem to be a very consistent approach to debate.
It's perfectly consistent.
--
| "Ridicule is the only weapon which can be used against |
| unintelligible propositions. Ideas must be distinct |
| before reason can act on them" -- Thomas Jefferson |
+-------- D. C. Sessions <dcs at (no spam) lumbercartel.com> ---------+ |
|
|
| Back to top |
|
| |
|
Page 1 of 1
All times are GMT - 5 Hours
The time now is Sat Nov 22, 2008 6:13 pm
|
|